China Sees Opportunities In Pharmaceutical Exports To Korea
This article was originally published in PharmAsia News
Executive SummaryWith South Korean pharmaceutical imports estimated to double from $3.2 billion in 2008 to $6.4 billion by 2013, domestic Chinese companies and multinationals alike see huge opportunities for growth
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.